---
$id: https://graph.org.ai/products/commodity/51161537
$type: Product
source: UNSPSC
code: "51161537"
title: "Enofelast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enofelast

**UNSPSC Code**: 51161537
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C16H15FO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3T93TS0430, chemically known as 2,6-dimethyl-4-(2-(4-fluorophenyl)ethenyl)phenol but generally known as enofelast, which bears US NIH Compound Identifier 6439222. European Medicines Agency schedules Enofelast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06538MIG. The term ENOFELAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ENOFELAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enofelast under HS 29081900 and SITC 51244. As of Q4 2014, ENOFELAST remains the US FDA Preferred Term for this commodity. Enofelast bears US NLM identifiers UMLS ID C0091793 and NCI Concept Code C74134. SMILES: FC1CCC(/C=C/C2CC(C(O)C(C2)C)C)CC1.

